Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Gene expression in papillary thyroid carcinoma reveals highly consistent profiles.

Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, de la Chapelle A.

Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15044-9.

2.

Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.

Puskas LG, Juhasz F, Zarva A, Hackler L Jr, Farid NR.

Cell Mol Biol (Noisy-le-grand). 2005 Sep 5;51(2):177-86.

PMID:
16171553
3.

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.

Montero-Conde C, Martín-Campos JM, Lerma E, Gimenez G, Martínez-Guitarte JL, Combalía N, Montaner D, Matías-Guiu X, Dopazo J, de Leiva A, Robledo M, Mauricio D.

Oncogene. 2008 Mar 6;27(11):1554-61. Epub 2007 Sep 17.

PMID:
17873908
4.

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.

Modlich O, Prisack HB, Pitschke G, Ramp U, Ackermann R, Bojar H, Vögeli TA, Grimm MO.

Clin Cancer Res. 2004 May 15;10(10):3410-21.

5.

Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma.

Ferrario C, Lavagni P, Gariboldi M, Miranda C, Losa M, Cleris L, Formelli F, Pilotti S, Pierotti MA, Greco A.

Lab Invest. 2008 May;88(5):474-81. doi: 10.1038/labinvest.2008.17. Epub 2008 Mar 10.

6.

Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.

Rohan S, Tu JJ, Kao J, Mukherjee P, Campagne F, Zhou XK, Hyjek E, Alonso MA, Chen YT.

Clin Cancer Res. 2006 Dec 1;12(23):6937-45.

7.

Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes.

Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, Davuluri RV, de la Chapelle A, Eng C.

J Clin Oncol. 2004 Sep 1;22(17):3531-9.

PMID:
15337802
8.

Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas.

Stolf BS, Abreu CM, Mahler-Araújo MB, Dellamano M, Martins WK, de Carvalho MB, Curado MP, Díaz JP, Fabri A, Brentani H, Carvalho AF, Soares FA, Kowalski LP, Hirata R Jr, Reis LF.

Cancer Lett. 2005 Sep 8;227(1):59-73. Epub 2005 Jan 18.

PMID:
16051032
9.
11.
12.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

13.

Gene expression in thyroid autonomous adenomas provides insight into their physiopathology.

Wattel S, Mircescu H, Venet D, Burniat A, Franc B, Frank S, Andry G, Van Sande J, Rocmans P, Dumont JE, Detours V, Maenhaut C.

Oncogene. 2005 Oct 20;24(46):6902-16.

PMID:
16027733
14.

Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.

Witte J, Lehmann S, Wulfert M, Yang Q, Röher HD.

World J Surg. 2007 Jan;31(1):51-9.

PMID:
17171498
15.

Gene expression in poorly differentiated papillary thyroid carcinomas.

Fluge Ø, Bruland O, Akslen LA, Lillehaug JR, Varhaug JE.

Thyroid. 2006 Feb;16(2):161-75.

PMID:
16676402
16.

Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.

El Demellawy D, Nasr AL, Babay S, Alowami S.

Pathol Res Pract. 2009;205(5):303-9. doi: 10.1016/j.prp.2008.11.011. Epub 2009 Jan 18.

PMID:
19153015
17.

A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.

Ngan ES, Lang BH, Liu T, Shum CK, So MT, Lau DK, Leon TY, Cherny SS, Tsai SY, Lo CY, Khoo US, Tam PK, Garcia-Barceló MM.

J Natl Cancer Inst. 2009 Feb 4;101(3):162-75. doi: 10.1093/jnci/djn471. Epub 2009 Jan 27.

PMID:
19176457
18.

Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma.

Baris O, Mirebeau-Prunier D, Savagner F, Rodien P, Ballester B, Loriod B, Granjeaud S, Guyetant S, Franc B, Houlgatte R, Reynier P, Malthiery Y.

Oncogene. 2005 Jun 9;24(25):4155-61.

PMID:
15806164
19.

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.

Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T.

Cancer Sci. 2008 Feb;99(2):280-6. doi: 10.1111/j.1349-7006.2007.00666.x. Epub 2008 Jan 14.

20.

Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas.

Liu RT, Huang CC, You HL, Chou FF, Hu CC, Chao FP, Chen CM, Cheng JT.

Oncogene. 2002 Jul 18;21(31):4830-7.

Supplemental Content

Support Center